Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study

Carvalhas Gabrielli, Anna Maria; Ferretti, Francesca; Monico, Camilla Maria; Tombetti, Enrico; Maconi, Giovanni; Romeo, Samanta; Piazza O Sed, Nicole; Caprioli, Flavio; Mazzola, Anna Maria; Alicante, Saverio; Bertè, Roberto; Lolli, Elisabetta; Scribano, Maria Lia; Buscarini, Elisabetta; Ricci, Chiara; Carmagnola, Stefania; Ardizzone, Sandro; Cannatelli, Rosanna

doi:10.1007/s10620-024-08394-w

Dig Dis Sci

2024

DOI: 10.1007/s10620-024-08394-w

|View full text |Cite

Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study

Anna Maria Carvalhas Gabrielli,

Francesca Ferretti,

Camilla Maria Monico

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Tofacitinib in Ulcerative Colitis – Second-Line Therapy, First-Rate Results

Harindranath

2024

Dig Dis Sci

View full text Add to dashboard Cite

Tofacitinib in Ulcerative Colitis – Second-Line Therapy, First-Rate Results

Harindranath

2024

Dig Dis Sci

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study

Cited by 1 publication

References 25 publications

Tofacitinib in Ulcerative Colitis – Second-Line Therapy, First-Rate Results

Tofacitinib in Ulcerative Colitis – Second-Line Therapy, First-Rate Results

Contact Info

Product

Resources

About